Minish Jain

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer

Giuseppe Giaccone, Lyudmila Bazhenova, John Nemunaitis et al. · European Journal of Cancer · 2015 · 266 citations

Vaccination, Tumor Immunology, Medicine +10

A Randomized Phase 2 Study of ADXS11-001 Listeria monocy'togenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer

Partha Basu, Ajay Mehta, Minish Jain et al. · International Journal of Gynecological Cancer · 2018 · 171 citations · Full text

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

Martin Schüler, James Chih‐Hsin Yang, K. Park et al. · Annals of Oncology · 2015 · 131 citations · Full text

Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Kevin J. Harrington, Stéphane Temam, Hisham Mehanna et al. · Journal of Clinical Oncology · 2015 · 102 citations

A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer

William J. Gradishar, Virginia Kaklamani, Tarini Prasad Sahoo et al. · European Journal of Cancer · 2012 · 84 citations

First-line Therapy, Breast Oncology, Medicine +6